Leonardo Brunetti

机构：Harvard University, Dana-Farber Cancer Institute

发表论文 1 篇

代表论文

• Impact of STK11 / KEAP1 / SMARCA4 co-mutations in RAS-activated KRAS wild-type metastatic NSCLC treated with immune checkpoint inhibitors. (2026 · Journal of Clinical Oncology)